These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 1127230

  • 1. Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer.
    Stolfi RL, Fugmann RA, Stolfi LM, Martin DS.
    J Immunol; 1975 Jun; 114(6):1824-30. PubMed ID: 1127230
    [Abstract] [Full Text] [Related]

  • 2. Carbodiimide enhancement of complement-dependent antibody-mediated tumor cell lysis in vitro and antitumor activity in vivo.
    Fawwaz RA, Tenforde TS, Mehlberg WH.
    Cancer Res; 1975 Mar; 35(3):679-86. PubMed ID: 1116128
    [Abstract] [Full Text] [Related]

  • 3. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors.
    Heppner GH, Calabresi P.
    J Natl Cancer Inst; 1972 Apr; 48(4):1161-7. PubMed ID: 5023677
    [No Abstract] [Full Text] [Related]

  • 4. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM, Zarling JM.
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [Abstract] [Full Text] [Related]

  • 5. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B, Deodhar SD.
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [Abstract] [Full Text] [Related]

  • 6. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J, Vetvicka V, Xia Y, Coxon A, Carroll MC, Mayadas TN, Ross GD.
    J Immunol; 1999 Sep 15; 163(6):3045-52. PubMed ID: 10477568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunity to the T1699 murine mammary tumor. I. Thymic influence and long-term effect of irradiation on the humoral response.
    Parthenais E, Haskill S.
    J Immunol; 1979 Sep 15; 123(3):1329-33. PubMed ID: 381522
    [Abstract] [Full Text] [Related]

  • 10. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O, Fortner GW, Lucas ZJ.
    J Immunol; 1975 Nov 15; 115(5):1282-7. PubMed ID: 1176776
    [Abstract] [Full Text] [Related]

  • 11. Generation of non-complement-fixing, blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies.
    Dauphinee MJ, Talal N, Witz IP.
    J Immunol; 1974 Sep 15; 113(3):948-53. PubMed ID: 4413555
    [No Abstract] [Full Text] [Related]

  • 12. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM, Woods WA, Mohr SJ, Chirigos MA.
    Cancer Res; 1976 May 15; 36(5):1641-6. PubMed ID: 1268825
    [Abstract] [Full Text] [Related]

  • 13. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA, Prehn RT.
    Cancer Res; 1972 Nov 15; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. 3. Plaque-forming cell response in lymph nodes and spleen.
    Rowland GF, Edwards AJ, Hurd CM, Sumner MR.
    J Natl Cancer Inst; 1971 Aug 15; 47(2):321-7. PubMed ID: 4934422
    [No Abstract] [Full Text] [Related]

  • 18. Natural history of mouse syngeneic lymphoma. Morphologic and immunologic aspects.
    Jurin M, Drewinko B.
    Am J Pathol; 1974 Nov 15; 77(2):213-36. PubMed ID: 4614670
    [Abstract] [Full Text] [Related]

  • 19. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
    Huber SA, Lucas ZJ.
    J Immunol; 1978 Dec 15; 121(6):2485-9. PubMed ID: 722081
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.